Document is current
Any future updates will be listed below
-
Authors
Ekman, Bertil https://orcid.org/0000-0001-8732-7361
Quinkler, Marcus
Zhang, Pinggao
Isidori, Andrea M.
Murray, Robert D.
Wahlberg, Jeanette
,
-
Funding
Funding for this research was provided by:
Linköping University
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 11 July 2025
First Online: 6 September 2025
Declarations
:
: B.E., M.Q., and R.D.M. have received fees for talks and consultancy from Shire, a member of the Takeda group of companies, and ViroPharma. P.Z. is employed by Takeda. A.M.I. has previously consulted for and was a primary investigator for Corcept Therapeutics, Diurnal, Neurocrine Biosciences, and Recordati. R.D.M. has previously consulted for Diurnal. J.W. has nothing to declare.
: This study was approved by the appropriate local research ethics committees for all participating centers and was conducted in accordance with the Declaration of Helsinki.
: Each patient and/or their parent/legal guardian provided written informed consent before enrollment in the European Adrenal Insufficiency Registry.
